XML 31 R21.htm IDEA: XBRL DOCUMENT v3.25.2
Note 2 - Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Exercise price per warrant

 $33.00 

Conversion rate - common shares per warrant

  1.50 

Closing price of common stock

 $23.72 

Volatility

  75%

Risk-free interest rate

  5.40%

Expected life of option (in years)

  0.3 

Dividend yield

 

zero

 
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Three months ended June 30,

  

Six months ended June 30,

 
  

2025

  

2024

  

2025

  

2024

 

Operating expenses

                

Research and development

 $(5,116) $(15,198) $(18,782) $(31,431)

General and administrative

  (40,276)  (46,204)  (51,196)  (49,905)

Other segment items(a)

  1,168   67,557   2,351   112,534 

Net income (loss)

 $(44,224) $6,155  $(67,627) $31,198 
    
  

June 30, 2025

  

December 31, 2024

 

Cash and cash equivalents

 $112,381  $128,574 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Three months ended

  

Six months ended

 
  

June 30,

  

June 30,

 
  

2025

  

2024

  

2025

  

2024

 

Numerator, basic:

                

Net income (loss)

 $(44,224) $6,155  $(67,627) $31,198 

Denominator, basic:

                

Weighted average common shares outstanding

  48,308   46,202   48,285   44,601 

Net income (loss) per share, basic

 $(0.92) $0.13  $(1.40) $0.70 
                 

Numerator, diluted:

                

Net income (loss)

 $(44,224) $6,155  $(67,627) $31,198 

Adjustment for change in fair value of warrant liabilities

           (43,793)

Adjusted numerator, diluted

 $(44,224) $6,155  $(67,627) $(12,595)

Denominator, diluted:

                

Weighted average common shares outstanding

  48,308   46,202   48,285   44,601 

Dilutive effect of common stock warrants

           551 

Weighted average dilutive common shares

  48,308   46,202   48,285   45,152 

Net income (loss) per share, diluted

 $(0.92) $0.13  $(1.40) $(0.28)
                 

Dilutive common stock options excluded from net income (loss) per share, diluted

  4,176   2,703   3,910   2,674 

Dilutive Performance Awards excluded from net income (loss) per share, diluted

  7   7   7   7